TITAN PHARMACEUTICALS INC (TTNP) Stock Analyst Earnings Estimates
NASDAQ:TTNP - Nasdaq - US8883147055 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.526M -68.46% | 557K -63.50% | 184K -66.97% | |
| EBITDA YoY % growth | -9.133M -29.38% | -10.039M -9.92% | -7.165M 28.63% | |
| EBIT YoY % growth | -9.354M -27.25% | -10.235M -9.42% | -7.277M 28.90% | |
| Operating Margin | -612.98% | -1,837.52% | -3,954.89% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -3.80 87.33% | -7.14 | 3.34 | 46.78% |
| Q2 2021 Q2Q % growth | -3.40 88.67% | -7.14 | 3.74 | 52.38% |
| Q1 2021 Q2Q % growth | -5.60 -166.67% | -17.34 | 11.74 | 67.70% |
| Q4 2020 Q2Q % growth | -17.20 64.17% | -27.13 | 9.93 | 36.61% |
| Q3 2020 Q2Q % growth | -30.00 72.22% | -21.42 | -8.58 | -40.06% |
| Q2 2020 Q2Q % growth | -30.00 86.84% | -21.42 | -8.58 | -40.06% |
| Q1 2020 Q2Q % growth | -2.10 98.97% | % | ||
| Q4 2019 Q2Q % growth | -48.00 | -48.96 | 0.96 | 1.96% |
| Q3 2019 Q2Q % growth | -108.00 | -131.58 | 23.58 | 17.92% |
| Q2 2019 Q2Q % growth | -228.00 | -153.00 | -75.00 | -49.02% |
| Q1 2019 Q2Q % growth | -204.00 | -159.12 | -44.88 | -28.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 4K -95.79% | % | ||
| Q2 2023 Q2Q % growth | 83K -44.67% | % | ||
| Q1 2023 Q2Q % growth | 98K -48.96% | % | ||
| Q4 2022 Q2Q % growth | 121K -10.37% | % | ||
| Q3 2022 Q2Q % growth | 95K -64.02% | % | ||
| Q2 2022 Q2Q % growth | 150K -66.29% | % | ||
| Q1 2022 Q2Q % growth | 192K -71.85% | % | ||
| Q4 2021 Q2Q % growth | 135K -90.14% | % | ||
| Q3 2021 Q2Q % growth | 264K -74.07% | 264K | % | |
| Q2 2021 Q2Q % growth | 445K -66.42% | 445K | % | |
| Q1 2021 Q2Q % growth | 682K -39.43% | 682K | % | |
| Q4 2020 Q2Q % growth | 1.369M 548.82% | 102K | 1.267M | 1,242.16% |
| Q3 2020 Q2Q % growth | 1.018M 7.50% | 918K | 100K | 10.89% |
| Q2 2020 Q2Q % growth | 1.325M 163.94% | 1.02M | 305K | 29.90% |
| Q1 2020 Q2Q % growth | 1.126M 19.15% | 839.46K | 286.54K | 34.13% |
| Q4 2019 Q2Q % growth | 211K | 943.5K | -732.5K | -77.64% |
| Q3 2019 Q2Q % growth | 947K | 714K | 233K | 32.63% |
| Q2 2019 Q2Q % growth | 502K | 947.58K | -445.58K | -47.02% |
| Q1 2019 Q2Q % growth | 945K | 1.122M | -177K | -15.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |